Methods of in-vitro analysis using time-domain NMR spectroscopy
AssigneeBayer HealthCare LLC
InventorsScott E. Carpenter, Thomas P. Benson
Life of this patent
Estimating the term…
Loading patent…
AssigneeBayer HealthCare LLC
InventorsScott E. Carpenter, Thomas P. Benson
Estimating the term…
An in vitro method of determining an analyte concentration of a sample includes placing the sample into a low-field, bench-top time-domain nuclear magnetic resonance (TD-NMR) spectrometer. The NMR spectrometer is tuned to measure a selected type of atom. A magnetic field is applied to the sample using a fixed, permanent magnet. At least one 90 degree radio-frequency pulse is applied to the sample. The radio-frequency pulse is generally perpendicular to the magnetic field. The 90 degree radio-frequency pulse is removed from the sample so as to produce a decaying NMR signal. The decaying NMR signal is measured at a plurality of times while applying a plurality of 180 degree refocusing radio-frequency pulses to the sample. The analyte concentration is calculated from the plurality of measurements associated with the decaying NMR signal and a selected model.
An in vitro method of determining an analyte concentration of a sample, the method comprising the acts of:
A method of determining an analyte concentration of a sample, the method comprising the acts of:
Dependencies are inferred from the claim text.